Comparison Between the Role of Follicular Output Rate and Preovulatory Count in the Prediction of Pregnancy in Women With Polycystic Ovarian Syndrome Undergoing Intra Cytoplasmic Sperm Injection (ICSI)
NCT02190006 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 300
Last updated 2017-01-23
Summary
Our study is observational, we are observing data from routine measurements during IVF/ICSI. Our study does not assess IVF/ICSI as an intervention, we are evaluating the role of FSI and preovulatory count which are calculated by observing routine measurements during the IVF/ICSI procedure.
300 women with polycystic ovarian syndrome (PCOS) who are decided to be treated with ICSI. will be subjected to full history taking and clinical examination. On the second day of menstruation serum FSH, LH, Prolactin and Oestradiol will be assessed and the antral follicular count (AFC) will be assessed using a vaginal ultrasound scan. AFC will be defined as the number of follicles measuring 3-10mm.
All patients will have standard pituitary down-regulation followed by follicle stimulating hormone (FSH) stimulation until the day of Human chorionic gonadotrophin (HCG) administration.
On the day of HCG administration, ovarian ultrasound scan will be performed using a transvaginal probe and the Preovulatory follicle count (PC) will be assessed, (PFC) is defined as number of follicles measuring≥16mm. Follicular output rate (FORT) will be calculated as: (FSI =PFC\*10000/AFC\*Total dose of FSH).
FORT correlation to pregnancy will be compared to that of the preovulatory count number
Conditions
- Polycystic Ovarian Syndrome
- Subfertility
- ICSI
Sponsors & Collaborators
-
Cairo University
lead OTHER
Principal Investigators
-
AbdelGany MA Hassan, MRCOG, MD · Cairo University
Eligibility
- Min Age
- 20 Years
- Max Age
- 40 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-07-31
- Primary Completion
- 2017-12-31
- Completion
- 2017-12-31
Countries
- Egypt
Study Locations
More Related Trials
-
Variation in Serum Prolactin Levels During IntraCytoplasmic Sperm Injection
NCT02292953 ·Status: UNKNOWN
-
Role of Ratio of Progesterone to Number of Follicles as a Prognostic Tool for IntracytoplasmicSperm Injection Outcome
NCT03105323 ·Status: UNKNOWN
-
A Study to Evaluate the Baseline Follicle Stimulating Hormone, Ovarian Volume and Antral Follicle Count as Prognostic Factors of the Outcome of In-vitro Fertilisation/Intracytosolic Sperm Injection in Infertile Patients Receiving Gonal f for Controlled Ovarian Hyperstimulation
NCT01196143 ·Status: COMPLETED
-
Progestin-primed Ovarian Stimulation Protocol Versus GnRH Antagonist Protocol in Polycystic Ovary Syndrome Patients Undergoing IVF/ICSI Cycles
NCT05112692 ·Status: UNKNOWN ·Phase: NA
-
Progesterone Primed Ovarian Stimulation Protocol Versus Antagonist Protocol for PCO Patient
NCT05847660 ·Status: UNKNOWN ·Phase: NA
-
Use of Low Dose of HCG During Ovulation Induction With CC in Women With CC Resistant PCOS
NCT02436226 ·Status: COMPLETED ·Phase: PHASE4
-
FSH/LH Ratio as a Predictor of IVF Outcome in Young and Older Women
NCT02674178 ·Status: COMPLETED ·Phase: PHASE4
-
The Effect of Pretreatment With Dydrogesterone Vs Combined Estradiol Valerate and Dydrogestrone on Clinical Pregnancy Outcome of ICSI in PCOS Patients"
NCT05300841 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
HCG Levels After Ovulation Triggering as Predictors of ICSI Outcome
NCT05969834 ·Status: COMPLETED
-
Letrozole Combined With Gonadotropins (Gn) for Ovarian Stimulation Undergoing in Vitro Fertilization/Intracytoplasmic Sperm Injection (IVF/ICSI) in Patients With Polycystic Ovary Syndrome (PCOS)
NCT00894608 ·Status: UNKNOWN ·Phase: NA
-
Effect of Timing of Oocyte Denudation Before ICSI in an Oocyte Donation Model
NCT03121924 ·Status: COMPLETED ·Phase: NA
-
Retrospective Trial on Low Prognosis Infertile Patients
NCT03290911 ·Status: COMPLETED
-
Effect of Fasting on ICSI Outcomes in Poor Responders
NCT03714009 ·Status: COMPLETED ·Phase: NA
-
Dydrogesterone-Primed Ovarian Stimulation Protocol Versus Gonadotropin Releasing Hormone Antagonist Protocol in ICSI
NCT05751681 ·Status: UNKNOWN ·Phase: NA
-
Clomiphene Citrate (CC) Co-treatment With HP Urinary FSH vs HP Urinary FSH in CC-resistant PCOS
NCT01212263 ·Status: COMPLETED ·Phase: NA
-
a Predictive Scheme for Poor Responders in IVF Cycles
NCT02351193 ·Status: COMPLETED
-
Progesterone Primed Ovarian Stimulation Versus GnRH Antagonist Protocols in Women With Polycystic Ovarian Syndrome
NCT06812559 ·Status: COMPLETED
-
Comparative Study of Long-acting and Short Acting Triptorelin in PCOS Patients Who Underwent IVF/ICSI
NCT02477566 ·Status: UNKNOWN ·Phase: NA
-
Long Protocol and Freeze All Embryos vs Antagonist Protocol With Fresh Embryo Transfer in PCOS Patients Undergoing ICSI
NCT03118830 ·Status: COMPLETED ·Phase: PHASE4
-
In Vitro Fertilization Outcomes of Two Treatment Protocols in Women With Polycystic Ovary Syndrome
NCT01354275 ·Status: TERMINATED ·Phase: NA
-
Effect of GnRH Agonist vs GnRH Antagonist on IVF/ICSI Outcomes in Polycystic Ovary Syndrome Patients.
NCT04727671 ·Status: COMPLETED ·Phase: PHASE4
-
Invitro Maturation of Oocytes for Patients With Polycystic Ovaries
NCT00631982 ·Status: UNKNOWN ·Phase: NA
-
Clinical and Live Birth Rates After Following Long Antagonist Protocol Versus Long Agonist Protocol
NCT03693534 ·Status: UNKNOWN
-
Timing of Initiation of Luteal Phase Support in Poor Responders Undergoing IVF/ICSI
NCT03938064 ·Status: UNKNOWN ·Phase: PHASE4
-
hMG or Recombinant FSH on OHSS Prevention in PCOS Patients Undergoing IVF
NCT01365936 ·Status: COMPLETED ·Phase: PHASE4